PharmaShots | Incisive News in 3 Shots

Subscribe Now

Otsuka Pharmaceutical

Otsuka Pharmaceutical to Acquire Jnana Therapeutics, Expanding its Autoimmune Portfolio and Drug Discovery Technologies

Otsuka Pharmaceutical to Acquire Jnana Therapeutics, Expanding its Autoimmune Portfolio and Drug Discovery Technologies

August 1, 2024

Otsuka Reports Results from the P-III Study of AVP-786 for Treating Agitation in Patients with Dementia Due to Alzheimer's Disease

Otsuka Reports Results from the P-III Study of AVP-786 for Treating Agitation in Patients with Dementia Due to Alzheimer's Disease

February 14, 2024

Otsuka Pharmaceutical Reports Results from Two P-III Trials of Centanafadine to Treat ADHD

Otsuka Pharmaceutical Reports Results from Two P-III Trials of Centanafadine to Treat ADHD

October 30, 2023

Otsuka Pharmaceutical to Acquire Mindset Pharma for ~$60M

Otsuka Pharmaceutical to Acquire Mindset Pharma for ~$60M

September 1, 2023

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us